Key Highlights
- Needham shifts stance on ARM to Buy rating from Hold, establishing a $200 price objective
- Company introduced its proprietary AGI CPU processor at the “Arm Everywhere” conference
- Meta Platforms becomes inaugural customer for ARM’s new chip technology
- Jefferies boosts price objective to $210, projecting $15B revenue opportunity through FY2031
- Latest quarterly results exceeded EPS projections ($0.43 actual vs $0.41 estimated) alongside 26.3% revenue growth
After maintaining a neutral position for approximately two and a half years, Needham elevated Arm Holdings to a Buy rating on Wednesday, establishing a 12-month price objective of $200.
Arm Holdings plc American Depositary Shares, ARM
The investment firm highlighted ARM’s strategic initiatives in the semiconductor space — increasing royalty pricing, moving into subsystems, and launching proprietary chip designs. According to Needham, these strategic moves are beginning to yield positive results.
ARM has delivered 26.45% revenue expansion across the trailing twelve-month period. Earnings projections for the coming period have been revised higher by nineteen Wall Street analysts.
Central to the upgrade rationale is ARM’s silicon market entry via its collaboration with Meta Platforms. Meta’s commitment as the inaugural customer for ARM’s debut in-house processor, the AGI CPU, provides the product with significant commercial validation immediately upon launch.
The AGI CPU made its official debut during ARM’s “Arm Everywhere” conference. Following this announcement, Jefferies elevated its price objective to $210 from $170, emphasizing the chip’s capacity to deliver $15 billion in incremental revenue by fiscal 2031.
Barclays maintained its Overweight recommendation while increasing its target to $200 from $165. The firm emphasized the AGI CPU’s energy-efficient architecture as a critical competitive advantage for artificial intelligence applications.
BofA Securities increased its target to $155 from $140 while maintaining a Neutral stance. Morgan Stanley preserved its Overweight rating with a $135 objective, acknowledging ARM’s innovative dual-chiplet CPU architecture tailored for cloud-based AI implementations.
Wall Street Consensus View
Current analyst consensus registers as a Moderate Buy, featuring an average price objective of $168.17. This assessment reflects 19 Buy recommendations, 6 Hold ratings, and 1 Sell rating.
ARM’s 50-day moving average currently trades at $120.72, while the 200-day moving average sits at $134.17. The stock’s 52-week trading range spans from $80.00 to $183.16, with a market capitalization approximately $165.95 billion.
The company trades at a P/E ratio of 209. InvestingPro analysis indicates the stock is presently trading above its Fair Value calculation.
During its latest quarterly report, ARM posted earnings per share of $0.43, surpassing analyst expectations of $0.41. Total revenue reached $1.24 billion, representing a 26.3% year-over-year increase and marginally exceeding the $1.23 billion Street estimate.
Forward-Looking Projections
ARM provided Q4 FY2026 guidance projecting EPS in the range of $0.54 to $0.62. The analyst community collectively anticipates full-year EPS of $0.90.
Needham emphasized the emergence of agentic AI technologies and the expanding importance of CPUs within AI data center infrastructure as sustained growth catalysts supporting ARM’s market position.
The AGI CPU targets agentic AI applications with its many-core, power-optimized architecture. Industry analysts observe that successful market penetration will require comprehensive software and hardware ecosystem development to challenge established competitors such as Nvidia, Intel, and AMD.
Susquehanna upgraded ARM from Neutral to Positive during January, setting a $150 target. Mizuho reduced its target from $190 to $160 in February while preserving an Outperform rating.
Institutional investors currently hold 7.53% of outstanding shares.



